Presentations, Performances & Exhibitions
Alzheimer’s Association Cognitive Screening and Blood-based Biomarker Guidelines
· April 17, 2026
Invited Talk
American Association of Geriatric Psychiatry (AAGP) Annual Meeting,
Arlington, VA
Long-Term Follow-up of AAV Gene Therapy (LX1001) in APOE4 Homozygotes with Alzheimer’s Disease
· March 26, 2026
Invited Talk
Alzheimer’s Disease Parkinson’s Diseases (AD/PD) Conference,
Copenhagen, Denmark
APOE2 AAV Gene Therapy in APOE4 Homozygotes with Alzheimer’s Disease: 1 Year Results from Phase 1/2 Study
· July 31, 2025
Invited Talk
Alzheimer's Association International Conference,
Toronto, Canada
ARIA Incidence and Management: Real world experience from the Duke Memory Disorders Clinic
· March 15, 2025
National Scientific Meeting
American Association of Geriatric Psychiatry (AAGP) Annual Meeting,
Phoenix, Arizona
Safety and Preliminary Efficacy of AAV Gene Therapy (LX1001) in Patients with APOE4 Homozygote Alzheimer’s Disease – Interim Data from a Phase 1/2, Open-Label, 52-Week, Multicenter Study
· October 30, 2024
International Meeting or Conference
Clinical Trial in Alzheimers Disease (CTAD) Congress,
Madrid, Spain
Chair’s Session on Navigating Neurotherapeutic Horizons: Managing the Practical Aspects of the Novel Alzheimer’s Therapeutics
· September 17, 2024
National Scientific Meeting
American Neurological Association (ANA) Annual Meeting,
Orlando, Florida
Overview of anti-amyloid therapies: Considerations for prescribing and monitoring
· May 8, 2024
National Scientific Meeting
American Psychiatric Association (APA) Annual Meeting,
New York, NY
Overview of anti-amyloid therapies: Considerations for prescribing and monitoring
· March 18, 2024
National Scientific Meeting
American Association of Geriatric Psychiatry (AAGP) Annual Meeting,
Atlanta, GA
Service to the Profession
Scholars Program Planning Committee, American Association of Geriatric Psychiatry
·
2017
- 2021
Committee Service
Service to Duke
Advisory Board, Project Summary: BEACON (Bridging Equity and Access in Care and Outcomes for DemeNtia)
·
February 2025
- February 2027
Other
Department of Population Health Sciences
Duke Skilled Nursing Facility COVID Advisory Team (Clinical Organization)
·
April 2020
Committee Service
Appointment, Promotions, Tenure Faculty Workgroup (Department)
·
August 2018
Committee Service
Psychiatry
Geriatrics Coordinating Council (Clinical Organization)
·
May 2018
Committee Service
Leadership & Clinical Positions
Division Chief, Memory Disorders Division, Department of Neurology
Director of Clinical Trials, Memory Disorders Division, Department of Neurology
Co-Leader, Clinical Core, Duke-UNC Alzheimer's Disease Research Center
Clinical Summary
Duke Neurology Memory Disorders Clinic